First Trust Advisors LP Kezar Life Sciences, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.85 - $9.73 $467,811 - $938,516	-96,456 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.93 - $6.46 $1,508 - $1,976	306 Added 0.32%	96,456 $524,000
Q1 2021 May 14, 2021	BUY	$5.24 - $6.99 $40,437 - $53,941	7,717 Added 8.73%	96,150 $573,000
Q4 2020 Feb 02, 2021	SELL	$4.77 - $6.58 $18,951 - $26,142	-3,973 Reduced 4.3%	88,433 $462,000
Q3 2020 Nov 05, 2020	BUY	$4.36 - $5.5 $402,890 - $508,233	92,406 New	92,406 $447,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.